Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Wasatch Ultra Growth Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 23.2% for the quarter, underperforming its benchmark, the Russell 2,000 Growth Index which returned 29.6% in the same quarter. You should check out Wasatch’s top 5 stock picks for investors […]
Tandem Diabetes Care today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.
Tandem Diabetes Care delivered a stronger-than-expected 4Q performance, driven by a 67% jump in its global pump shipments. Shares of the insulin delivery and diabetes technology company were up about 4% at end of trading on Feb. 25. Tandem Diabetes (TNDM) posted adjusted earnings of $0.22 per share, exceeding analysts’ expectations of $0.12 per share. Its revenue increased 55% year-on-year to hit $168.1 million, topping analysts’ estimates of $141.6 million. In 4Q, while its domestic pump shipme...
Today's discussion will include forward-looking statements. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.
Shares of Tandem Diabetes Care (NASDAQ:TNDM) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 450.00% year over year to $0.22, which beat the estimate of $0.12. Revenue of $168,065,000 higher by 55.04% year over year, which beat the estimate of $141,580,000. Outlook Earnings guidance hasn't been issued by the company for now. The upcoming fiscal year's revenue expected to be between $600,000,000 and $615,000,000. Details Of The Ca...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2020 and financial guidance for the year ending December 31, 2021.